Fisher Dachs Associates is one of the world’s leading theatre planning and design consultants. Our mission is to help our clients plan and design vibrant, innovative, and technically superb performance spaces and cultural buildings for a wide range of uses. Collaboration is key to what we do.
Founded by legendary Broadway lighting designer Jules Fisher, and under the direction of Joshua Dachs, FDA has over 50 years’ experience in providing guidance to over 1,000 performing arts projects. These range from small community theatres to major cultural centers worldwide and includes theaters for drama, dance and musicals; concert halls; opera houses; multi-purpose touring venues; higher education and academic institutions; corporate auditoriums and event spaces; rock’n’roll clubs and popular music venues.
Our goal is to craft buildings that are easy to find your way around, are great places to visit, work, or perform in, and that function equally well for the artists who work in the space, the technical staff who keep it running smoothly, and the management team that has to operate it successfully. To do that we draw on our deep experience and listen closely to our clients, their staff, and their stakeholders.
Our staff includes people with backgrounds as set and lighting designers, musicians, architects, stage technicians, production managers, producers, and stage managers. Our work is kept fresh because we’re still actively involved in production, whether its Jules Fisher’s work on Broadway or our work designing unique performance environments for over 20 productions at the Park Avenue Armory.
Our firm’s clients include architects, cultural organizations, universities, government agencies, commercial investors, and property developers. We have completed projects in Canada, China, Columbia, Egypt, England, Hong Kong, Jamaica, Japan, Korea, Mexico, Philippines, Russia, Saudi Arabia, Singapore, Spain, and the UAE, in addition to the USA.
FDA Approves Monthly IV Maintenance Dosing of Lecanemab for Adults with Early Alzheimer Dementia: A First in Long-Term Disease Management Patient Care Online
Eisai and Biogen Start Rolling Biologics License Application Submission to FDA for Subcutaneous Version of Alzheimer Disease Drug Leqembi Applied Clinical Trials
Hepatitis Delta Treatment Combination Receives FDA IND Clearance and Fast Track Designation Following Positive Phase II Results Applied Clinical Trials
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.